EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus

Megolhubino Terhüja, Manjunath Siddappa, Pramila Lamichhane iD, Chetan D Meshram, Timothy A Snider iD, Jerry W Ritchey, Antonius G P Oomens iD

Viruses · 2024

DOI: 10.3390/v16060843 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Megolhubino Terhüja und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA. Hauptthemen laut MEDLINE: Antibodies, Viral, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines, Vaccines, Virus-Like Particle. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory syncytial virus (RSV) is a major cause of severe respiratory tract disease worldwide, and a pediatric vaccine is not available. We generated a filamentous RSV-based virus-like particle (VLP) that presents the central conserved region of the attachment protein G. This was achieved by co-expressing the matrix protein, phosphoprotein, nucleoprotein, and a hybrid fusion protein in which the F ectodomain was replaced with the G central region (GCR). The latter is relatively conserved and contains a receptor binding site and hence is a logical vaccine target. The immunogenicity and efficacy of the resulting VLP, termed VLP-GCR, were examined in mice using intranasal application without adjuvant. VLP-GCR induced substantial anti-N antibody levels but very low anti-G antibody levels, even after three vaccinations. In contrast, a VLP presenting prefusion-stabilized fusion (preF) protein instead of GCR induced both high anti-F and anti-nucleoprotein antibody levels, suggesting that our GCR antigen was poorly immunogenic. Challenge of VLP-GCR-vaccinated mice caused increased weight loss and lung pathology, and both VLPs induced mucus in the lungs. Thus, neither VLP is suitable as a vaccine for RSV-naive individuals. However, VLP-preF enhanced the proportion of preF antibodies and could serve as a multi-antigen mucosal booster vaccine in the RSV-experienced population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesVaccines, Virus-Like ParticleAnimalsFemaleHumansMiceAdministration, IntranasalLungMice, Inbred BALB CRespiratory Syncytial Virus, HumanVaccinationViral Envelope ProteinsViral Fusion ProteinsWeight Loss

Stichwörter der Autor:innen

G proteinprefusion Frespiratory syncytial virus (RSV)vaccinevirus-like particle (VLP)

Substanzen

Antibodies, ViralRespiratory Syncytial Virus VaccinesVaccines, Virus-Like ParticleViral Envelope ProteinsViral Fusion Proteins

Autor:innen und Institutionen

  • Department of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA.
  • Department of Veterinary Sciences and Animal Husbandry, Chitradurga 577502, Karnataka, India.
  • RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy, Immunology, and Infectious Diseases, NIH, Bethesda, MD 20892, USA.
  • CSIR-Central Drug Research Institute, Lucknow 226031, Uttar Pradesh, India.

ORCID-Profile: Pramila Lamichhane, Timothy A Snider, Antonius G P Oomens

Förderung

  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Terhüja, M., Siddappa, M., Lamichhane, P., Meshram, C. D., Snider, T. A., Ritchey, J. W., & Oomens, A. G. P. (2024). Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus. Viruses. https://doi.org/10.3390/v16060843

Vancouver

Terhüja M, Siddappa M, Lamichhane P, Meshram CD, Snider TA, Ritchey JW, et al. Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus. Viruses. 2024. doi:10.3390/v16060843

BibTeX
@article{Terhja2024,
  author = {Terhüja, Megolhubino and Siddappa, Manjunath and Lamichhane, Pramila and Meshram, Chetan D and Snider, Timothy A and Ritchey, Jerry W and Oomens, Antonius G P},
  title = {Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16060843}
}
Kostenlos starten →